BridgeBio price target raised to $52 from $49 at Scotiabank
Scotiabank raised the firm’s price target on BridgeBio (BBIO) to $52 from $49 and keeps an Outperform rating on the shares. The company’s earnings release reflects “stellar commercial momentum” in the ...
Guardant Health price target raised to $56 from $42 at TD Cowen
TD Cowen analyst Dan Brennan raised the firm’s price target on Guardant Health (GH) to $56 from $42 and keeps a Buy rating on the shares. The firm said results were inline with the preannouncement ...